Design, synthesis, and biological evaluation of 2-hydroxy-4-phenylthiophene-3-carbonitrile as PD-L1 antagonist and its comparison to available small molecular PD-L1 inhibitors
<p>In search of a potent small molecular PD-L1 inhibitor, we designed and synthesized a compound based on a 2-hydroxy-4-phenylthiophene-3-carbonitrile moiety. Ligand’s performance was tested in vitro and compared side-by-side with a known PD-L1 antagonist with a proven bioactivity BM...
Main Authors: | Ważyńska, MA, Butera, R, Requesens, M, Plat, A, Zarganis-Tzitzikas, T, Neochoritis, CG, Plewka, J, Skalniak, L, Kocik-Krol, J, Musielak, B, Magiera-Mularz, K, Rodriguez, I, Blok, SN, de Bruyn, M, Nijman, HW, Elsinga, PH, Holak, TA, Dömling, A |
---|---|
Format: | Journal article |
Language: | English |
Published: |
American Chemical Society
2023
|
Similar Items
-
Biphenyl ether analogs containing pomalidomide as small-molecule inhibitors of the programmed cell death-1/programmed cell death-ligand 1 interaction
by: Shaabani, S, et al.
Published: (2022) -
Structural and biological characterization of pAC65, a macrocyclic peptide that blocks PD-L1 with equivalent potency to the FDA-approved antibodies
by: Ismael Rodriguez, et al.
Published: (2023-09-01) -
Biphenyl Ether Analogs Containing Pomalidomide as Small-Molecule Inhibitors of the Programmed Cell Death-1/Programmed Cell Death-Ligand 1 Interaction
by: Shabnam Shaabani, et al.
Published: (2022-05-01) -
Structural Characterization of a Macrocyclic Peptide Modulator of the PD-1/PD-L1 Immune Checkpoint Axis
by: Edyta Zyla, et al.
Published: (2021-08-01) -
Competition NMR for Detection of Hit/Lead Inhibitors of Protein–Protein Interactions
by: Bogdan Musielak, et al.
Published: (2020-07-01)